UPDATE: Stifel Nicolaus Lowers PT on Ixia to $17

Stifel Nicolaus is out with its report today on Ixia XXIA, lowering its PT from $21 to $17. In a note to clients, Stifel Nicolaus writes, "We are reducing our 2011 sales estimate from $328.5 million to $299.5 million and our pro forma EPS estimate from $0.71 to $0.51. We are reducing our 2012 sales estimate from $390 million to $340 million and our pro forma EPS estimate from $1.00 to $0.73. We are lowering our 12-month price target from $21 to $17 on lower estimates. Our new 12-month price target of $17 for XXIA is based on 23x our 2012 pro forma EPS estimate of $0.73, relative to our estimated pro forma EPS growth of 42% in 2012." At the time of posting, shares of XXIA were trading at $9.79, down 24.75% from Thursday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsCommunications EquipmentInformation TechnologyIxiaStifel Nicolaus
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!